Quick Answer
XBiotech Inc. reported Stockholders Equity of $140.35 million for fiscal year 2025.
XBiotech Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $140.35M | -23.0% |
| 2024 | $182.27M | -16.7% |
| 2023 | $218.85M | -9.0% |
| 2022 | $240.40M | -10.8% |
| 2021 | $269.38M | -22.7% |
| 2020 | $348.64M | -53.9% |
| 2019 | $755.63M | +1725.3% |
| 2018 | $41.40M | -31.2% |
| 2017 | $60.16M | +1.9% |
| 2016 | $59.06M | -42.7% |
| 2015 | $103.05M | +74.6% |
| 2014 | $59.03M | +477.1% |
| 2013 | $10.23M | +38.7% |
| 2012 | $7.37M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $167.08M | -13.0% | -3.5% |
| June 30, 2025 | $173.06M | -12.0% | -0.9% |
| March 31, 2025 | $174.71M | -16.5% | -4.1% |
| December 31, 2024 | $182.27M | -16.7% | -5.1% |
| September 30, 2024 | $192.12M | -13.7% | -2.3% |
| June 30, 2024 | $196.70M | -14.1% | -6.0% |
| March 31, 2024 | $209.28M | -11.7% | -4.4% |
| December 31, 2023 | $218.85M | -9.0% | -1.7% |
- XBiotech Inc. showed a decrease of -23.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2025 period, XBiotech Inc.’s stockholders equity has grown by 1803.8% (from $7.37 million to $140.35 million).
- The most recent figure is from XBiotech Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: